EGFR and neoplasm: According to our findings, the cell cycle, ERBB signaling pathway, mismatch repair, p53 signaling pathway, ubiquitin-mediated protein hydrolysis, WNT signaling pathway, and various other processes associated with tumor proliferation and progression may contribute to the high-risk group’s poor prognosis.